Therapeutic effects of the combination of fenretinide and all-trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin-resistant sub-line

By Formelli F.   Cleris L.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2411-2419

Elsevier

Access to resources Recommend Favorite

Effect of topotecan infusion duration on hematologic toxicity in recurrent ovarian carcinoma

By Puls Larry   Hunter James   Crane Martin  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 25-33

Humana Press, Inc

Access to resources Recommend Favorite

Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line

By Hata Kohkichi   Osaki Mitsuhiko   Dhar Dipok   Nakayama Kentaro   Fujiwaki Ritsuto   Ito Hisao   Nagasue Naofumi   Miyazaki Kohji  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 68-74

Springer Publishing Company

Access to resources Recommend Favorite

Ovarian Carcinoma, Endometrial Carcinoma, and Pregnancy

By Foersterling D.L.   Blythe J.G.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 425-426

Elsevier

Access to resources Recommend Favorite

Ovarian Metastasis in Endometrial Carcinoma

By Takeshima N.   Hirai Y.   Yano K.   Tanaka N.   Yamauchi K.   Hasumi K.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 183-187

Elsevier

Access to resources Recommend Favorite